Pfizer, Flynn charged 'unfairly high' prices for epilepsy drugs, UK says

Pfizer accused of overcharging NHS for epilepsy drugs

The regulator argued that debranding the drug had allowed the pharma firms to raise prices overnight

Pfizer ‘exploited NHS loophole’ to raise price of epilepsy drug

Pfizer exploited loophole to overcharge NHS for epilepsy drug

Drugs firms Pfizer and Flynn broke law with 2,600% price increase for epilepsy tablets to NHS, UK watchdog finds

The companies exploited a loophole, sending the cost of the treatment preventing life-threatening seizures soaring by up to 2,600% "overnight", says the Competition and Markets Authority.

Pfizer accused of 'unfair' pricing as cost soars 2,600%

NHS spending on epilepsy drug rise from around £2 million a year in 2012 to about £50 million in 2013

Pfizer charged 'unfairly high' prices for epilepsy drug, UK regulator says

Drugmakers Pfizer Inc and Flynn broke competition law by charging Britain's National Health Service (NHS) “unfairly high” prices for an epilepsy medicine, a regulator said on Thursday after reassessing a fine imposed in 2016.

Pfizer and Flynn accused of overcharging NHS for anti-epilepsy drugs

Competition regulator the CMA alleges drugs firms abused dominant position with unfairly high prices